Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SULFATED CCR5 PEPTIDES FOR HIV-1 INFECTION
Document Type and Number:
WIPO Patent Application WO2001064710
Kind Code:
A8
Abstract:
This invention provides a compound comprising the structure: thetaalphaYDINYYTSEbetalambda wherein each T represents a threonine, each S represents a serine, each E represents a glutamic acid, each Y represents a tyrosine; each D represents an aspartic acid, each I represents an isoleucine; and each N represents an asparagine; wherein alpha represents from 0 to 9 amino acids, with the proviso that if there are more than 2 amino acids, they are joined by peptide bonds in consecutive order and have a sequence identical to the sequence set forth in SEQ ID NO: 1 beginning with the I at position 9 and extending therefrom in the amino terminal direction; wherein beta represents from 0 to 13 amino acids, with the proviso that if there are more than 2 amino acids, they are joined by peptide bonds in consecutive order and have a sequence identical to the sequence set forth in SEQ ID NO: 1 beginning with the P at position 19 and extending therefrom in the carboxy terminal direction; wherein theta represents an amino group or an acetylated amino group; wherein lambda represents a carboxyl group or an amidated carboxyl group; wherein all of alpha,Y,D,I,N,Y,Y,T,S,E and beta are joined together by peptide bonds; further provided that at least two tyrosines in the compound are sulfated.

Inventors:
DRAGIC TATJANA (US)
OLSON WILLIAM C (US)
Application Number:
PCT/US2001/006699
Publication Date:
December 31, 2003
Filing Date:
February 28, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PROGENICS PHARM INC (US)
AARON DIAMOND AIDS RES CT (US)
DRAGIC TATJANA (US)
OLSON WILLIAM C (US)
International Classes:
C07K14/715; C07K16/28; A61K38/00; (IPC1-7): A61K39/00; C07K7/00; C07K7/06; C07K7/08; G01N33/53; G01N33/566
Download PDF: